Drug Profile
Typhoid-tetanus toxoid conjugate vaccine - Zydus Lifesciences
Alternative Names: Tetanus-typhoid toxoid conjugate vaccine - Zydus Lifesciences ; Typhoid Vi capsular polysaccharide tetanus toxoid conjugate vaccine; Typhoid Vi conjugate vaccine; Vi Capsular polysaccharide vaccine - Zydus Lifesciences ; ZyVAC-TCVLatest Information Update: 21 Mar 2022
Price :
$50
*
At a glance
- Originator Cadila Healthcare
- Developer Zydus Lifesciences
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Typhoid
Most Recent Events
- 30 Jan 2020 Launched for Typhoid (In volunteers, In adults) in India before January 2020 (IM).
- 24 Apr 2015 Phase-I clinical trials in Typhoid (In adults, In volunteers) in India (IM) (CTRI2015-04-005710)